Cargando…
Acute asymptomatic hyponatraemia following inpatient initiation of angiotensin receptor–neprilysin inhibitor: a case report
BACKGROUND: Utilization of sacubitril/valsartan is increasing as a component of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (HFrEF). Common adverse effects associated with the medication such as hypotension and hyperkalaemia have been described; h...
Autores principales: | Dean, John-Henry L, Patel, Mayank P, Corpuz, Elaine, Cahill, Michael S, Fentanes, Emilio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010475/ https://www.ncbi.nlm.nih.gov/pubmed/36923116 http://dx.doi.org/10.1093/ehjcr/ytad060 |
Ejemplares similares
-
Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021) -
Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
por: Sutanto, Henry, et al.
Publicado: (2021) -
Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023) -
The diagnosis and management of inpatient hyponatraemia and SIADH
por: Grant, Paul, et al.
Publicado: (2015) -
Safety of the neprilysin/renin-angiotensin system inhibitor LCZ696
por: Li, Bo, et al.
Publicado: (2017)